Role of the tumor microenvironment in the lymphatic metastasis of cervical cancer (Review)

Exp Ther Med. 2023 Sep 1;26(4):486. doi: 10.3892/etm.2023.12185. eCollection 2023 Oct.

Abstract

Lymphatic metastasis is the primary type of cervical cancer metastasis and is associated with an extremely poor prognosis in patients. The tumor microenvironment primarily includes cancer-associated fibroblasts, tumor-associated macrophages, myeloid-derived suppressor cells, immune and inflammatory cells, and blood and lymphatic vascular networks, which can promote the establishment of lymphatic metastatic sites within immunosuppressive microenvironments or promote lymphatic metastasis by stimulating lymphangiogenesis and epithelial-mesenchymal transformation. As the most important feature of the tumor microenvironment, hypoxia plays an essential role in lymph node metastasis. In this review, the known mechanisms of hypoxia, and the involvement of stromal components and immune inflammatory cells in the tumor microenvironment of lymphatic metastasis of cervical cancer are discussed. Additionally, a summary of the clinical trials targeting the tumor microenvironment for the treatment of cervical cancer is provided, emphasizing the potential and challenges of immunotherapy.

Keywords: cancer-associated fibroblast; cervical cancer; lymphatic metastasis; tumor microenvironment; tumor-associated macrophage.

Publication types

  • Review

Grants and funding

Funding: This work was supported by the National Natural Science Foundation of China (grant no. 81902140).